Send mail to Author

Sorafenib sensitizes glioma cells to the BH3 mimetic ABT-737 by targeting MCL1 in a STAT3-dependent manner (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______    ______    ______    _____      _____   __   __  
 /_   _//  /_   _//  /_   _//  |  ___||   / ___//  \ \\/ // 
   | ||     -| ||-     | ||    | ||__     \___ \\   \ ` //  
  _| ||     _| ||_    _| ||    | ||__     /    //    | ||   
 /__//     /_____//  /__//     |_____||  /____//     |_||   
 `--`      `-----`   `--`      `-----`  `-----`      `-`'   
                                                            
 


Back to frontdoor view